**Why study this course?**
London Met’s Cancer Pharmacology master's course explores the nature of cancer at the systems, cellular and molecular levels, and focuses on the drugs which are used to treat different cancers and how they work. By the end of the MSc, you will have developed a deep understanding of how chemotherapeutic agents are used to target and kill cancer cells as part of a central strategy in the treatment of cancers.
In the most recent (2015'16) Destinations of Leavers from Higher Education (DLHE) survey, 100% of graduates from this course were in work or further study within six months.
**More about this course**
With worldwide cancer rates increasing and expected to reach 22 million new cases per year by 2030, this postgraduate course introduces you to how radiotherapy, surgery and chemotherapy have a vital role to play in prolonging the lives of patients.
We’ll provide you with an in'depth understanding of the molecular targets at which the different classes of anticancer drugs are aimed, and of how drug therapies are evolving. You’ll also review the biology of cancer with respect to genetics, pathological considerations and the molecular changes within cells which are associated with the progression of the disease.
You'll be taught by staff who are experienced researchers in areas such as cancer biology, immunology, genetics and bioinformatics. They will help you learn how to collect, analyse, interpret and understand scientific data you must make use of in the cancer pharmacology field. This ensures you’ll not only improve your intellectual knowledge but your practical skills as well.
Your laboratory'based project will be conducted in our £30 million Science Centre. This includes access to extensive cell culture facilities, electrophoresis equipment, polymerase chain reaction (PCR) cyclers and high performance liquid chromatography (HPLC) instrumentation.
Overall, this programme of advanced study provides you with the necessary skills, knowledge and understanding for you to pursue a career in anti'cancer drug development.
Core modules include:
Cancer: Diagnosis and Treatment
Scientific Frameworks for Research
Optional modules include:
Drug Discovery Technology
Advanced Drug Formulation Technologies
|Duration & Attendance||Qualification||Tuition fees||Fee type|
- You will be required to have a lower second class (2.2) UK first degree (or equivalent) in an appropriate subject, for example pharmacology, biomedical science, biological science or medical genetics. All applicants must be able to demonstrate proficiency in the English language.